Australia's largest stock trading and investment forum Australia's #1 stock forum

ACTINOGEN MEDICAL LIMITED

3.70%

2.8¢

Market Cap $88.91M

Healthcare Biotechnology

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel... Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long term cognitive health.More

Recently Updated

Corporate Spotlight

Actinogen is a neurotherapeutics developer realizing a revolutionary therapy so neurology patients and their families can live their best lives.
View the full Corporate Spotlight

Actinogen reaches 100th participant milestone

Latest Threads

Tag

Subject

ACW , exciting 6 months ahead !

2

09/09/25

61

12K

09/09/25

Last post Stealth101

61

12K

Ann: ACW FY2025 results - accelerating Alzheimers pivotal trial

08/09/25

21

4.8K

08/09/25

Last post Christian Dyor

21

4.8K

Ann: ACW updated depression trial results and implications

29/08/25

53

31K

29/08/25

Last post Sweetmole

53

31K

Ann: Application for quotation of securities - ACW

29/08/25

0

160

29/08/25

Last post

ASX News

0

160

Ann: Notification of cessation of securities - ACW

26/08/25

0

141

26/08/25

Last post

ASX News

0

141

Ann: ACW pharmacokinetics trial success

26/08/25

10

2.0K

26/08/25

Last post csrwin

10

2.0K

Ann: Appendix 4G

25/08/25

0

161

25/08/25

Last post

ASX News

0

161

Ann: Corporate Governance Statement

25/08/25

0

228

25/08/25

Last post

ASX News

0

228

Ann: ACW Appendix 4E and 2025 annual report

25/08/25

0

218

25/08/25

Last post

ASX News

0

218

Ann: ACW CEO Q&A at Bioshares 2025

24/08/25

36

10K

24/08/25

Last post IndexInvestor

36

10K

Ann: ACW accesses up to $13.8m in non-dilutive R&D tax funding

24/08/25

13

4.5K

24/08/25

Last post IndexInvestor

13

4.5K

Ann: Notification of buy-back - ACW

07/08/25

6

3.0K

07/08/25

Last post revolution

6

3.0K

Ann: Actinogen June 2025 quarterly activity report & Appendix 4C

30/07/25

1

1.0K

30/07/25

Last post butcherano

1

1.0K

Ann: ACW presents key clinical data at AAIC dementia meeting

28/07/25

2

1.3K

28/07/25

Last post stormer

2

1.3K

2025 will be the year

3 4 5

25/07/25

282

116K

25/07/25

Last post stormer

282

116K

Ann: ACW 100th AD trial participant & interim analysis timeline

18/07/25

23

12K

18/07/25

Last post jellyroll

23

12K

See All Discussions

Corporate Spotlight

ABOUT US

Timeline

Application for quotation of securities - ACW
29 Aug 11:29	Share

Notification of cessation of securities - ACW
26 Aug 16:22	Share

ACW pharmacokinetics trial success
26 Aug 10:41	Share

Appendix 4G
25 Aug 18:47	Share

Corporate Governance Statement
25 Aug 18:46	Share

ACW FY2025 results - accelerating Alzheimers pivotal trial
25 Aug 18:46	Share

ACW Appendix 4E and 2025 annual report
25 Aug 18:42	Share

ACW CEO Q&A at Bioshares 2025
07 Aug 08:27	Share

Actinogen June 2025 quarterly activity report & Appendix 4C
30 Jul 08:55	Share

Notification of buy-back - ACW
30 Jul 08:31	Share

ACW presents key clinical data at AAIC dementia meeting
28 Jul 09:46	Share

ACW accesses up to $13.8m in non-dilutive R&D tax funding
30 Jun 09:11	Share

ACW 100th AD trial participant & interim analysis timeline
30 Jun 08:57	Share

ACW presents at BIO international partnering conference
16 Jun 09:00	Share

Ceasing to be a substantial holder
21 May 08:21	Share

Actinogen CMO presents positive depression data at APA 2025
19 May 11:04	Share

ACW Science Forum today - Preparing for commercialization
15 May 09:21	Share

Actinogen March 2025 quarterly activity report & Appendix 4C
30 Apr 09:05	Share

ACW Science Forum notice - Preparing for commercialization
24 Apr 08:28	Share

Change in substantial holding
23 Apr 11:18	Share

ACW CMO presents Xanamem pTau poster at ADPD25 conference
02 Apr 12:28	Share

ACW conducts Type C meeting with FDA regarding depression
27 Mar 11:58	Share

Actinogen presentation to ASX small & mid-caps conference
26 Mar 11:06	Share

Appendix 3Ys x 5
24 Mar 16:58	Share

Notification of cessation of securities - ACW
24 Mar 16:44	Share

Notification of cessation of securities - ACW
24 Mar 16:44	Share

Application for quotation of securities - ACW
24 Mar 16:42	Share

Results of Meeting
14 Mar 10:35	Share

Notification of buy-back - ACW
04 Mar 16:56	Share

ACW HY25 results Advancing to latestage clinical development
24 Feb 15:28	Share

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.8¢		Change 0.001(3.70%)		Mkt cap ! $88.91M

Open	High	Low	Value	Volume
2.8¢	2.8¢	2.7¢	$12.00K	444.5K

Buyers (Bids)

No.	Vol.	Price($)
1	530460	2.7¢

Sellers (Offers)

Price($)	Vol.	No.
2.8¢	1529473	6

View Market Depth

No.	Vol.	Price($)
1	530460	0.027
12	1996115	0.026
11	2380415	0.025
10	2408530	0.024
5	990234	0.023

Price($)	Vol.	No.
0.028	1529473	6
0.029	525000	2
0.030	805084	5
0.031	798418	4
0.032	3770500	6

Last trade - 16.10pm 09/09/2025 (20 minute delay)

ACW (ASX) Chart